论文部分内容阅读
目的 观察应用米非司酮治疗子宫肌瘤的效果。 方法 口服米非司酮 12 .5mg,每日1次 ,连续 3个月为一疗程。 结果 78例中有 6 2例经过 5年临床观察 ,子宫肌瘤体积缩小4 1.81% ,用药过程中均闭经 ,贫血得以纠正。围绝经期可致绝经。因用药后肌瘤缩小 ,界限清楚 ,可作为子宫切除术和肌瘤剔除术术前用药 ,减少术中出血。 结论 经 5年观察 ,米非司酮治疗子宫肌瘤有临床应用价值
Objective To observe the effect of mifepristone treatment of uterine fibroids. Methods oral mifepristone 12.5mg, 1 day, for 3 months as a course of treatment. Results Sixty-two of 78 patients underwent 5-year clinical observation. The volume of uterine fibroids was reduced by 4.81%. Amenorrhoea and anemia were corrected in the course of medication. Perimenopausal menopause can cause. Due to narrowing of fibroids after treatment, clear boundaries, can be used as hysterectomy and myomectomy preoperative medication to reduce intraoperative bleeding. Conclusion After 5 years of observation, mifepristone has clinical value in the treatment of uterine fibroids